Archives for March 2024

March on with a New Issue of JASE

The March issue of JASE is now online with much to showcase including a variety of clinical investigations ranging from safety of ultrasound enhancement agents, noninvasive testing for coronary heart disease, Doppler in valvular heart disease, 3D TEE after transcatheter mitral valve repair and outcome, septal perforator flow in HCM, and LV function in children with chronic kidney disease. A handful of editorials and letters to the editor accompany two brief research communications to round out this issue.

Dr. Pellikka’s editorial outlines the artificial intelligence content of particular interest to JASE for authors interested in submitting on this topic. Finally, Dr. Eidem’s President’s Message highlights congenital heart disease and ASE’s efforts to bring education and awareness to this important patient population during his presidency. Be sure to check out March’s Author Spotlight that features Mays T. Ali, MD, and Jeremy J. Thaden, MD, FASE, discussing their recent paper on adverse drug reactions to ultrasound enhancement agents.

Learn more here about the March issue and read what author Idan Roifman, MD, MSc, had to say about highlighted paper, “Comparing Costs of Noninvasive Cardiac Diagnostic Tests—a Population-Based Study.”

ASE 2024 Schedule at a Glance is Now Online!

The countdown to ASE’s 35th Annual Scientific Sessions has officially started! In just 100 days, the premier cardiovascular ultrasound event of the year will begin, and now is the time to make your plans to attend.

Download the Schedule at a Glance, which offers a first look at all sessions and times available during the conference. The new format this year will focus on short cases with panel discussions, more audience participation, and less didactic presentations. We can’t wait for you to experience this new way of learning June 14-16 in Portland, OregonRegister and reserve your hotel room early to save.

Online Now: CASE Special Issue on ACHD

CASE Special Issue on ACHD

The CASE editorial team is pleased to announce that the Special Issue on Adult Congenital Heart Disease, with current ASE President, and pediatric cardiologist, Benjamin W. Eidem, MD, FASE, as guest editor is available today! Vincent L. Sorrell, MD, FASE, CASE Editor-in-Chief, notes that, “Congenital heart disease is the most common birth defect diagnosed in nearly 1% of all U.S. births. Two-thirds of this population are now over 18 years old due to advances in medical and surgical care. In fact, every year there are nearly 20,000 new ACHD patients. I think you will agree when you read this collection of reports that there are many examples provided in one place to help educate your colleagues, sonographers, trainees, and students wherever you work. We are so thankful for the many authors who took the time to provide their case reports for us to learn from.”

This Special Issue provides over 30 high-quality cases to explore on common and uncommon imaging findings that encompass typical and atypical presentations of patients encountered in an adult echocardiography lab.  The cases include descriptions of a wide range of congenital heart diseases, provide steps in image acquisition unique to the pathology and repair, describe the incremental role for collaborative multimodality imaging, and educate through patient examples using fascinating figures and videos you will undoubtedly keep on hand for future reference.

CASE is ASE’s open access journal allowing you to share these reports with colleagues across the globe.

March on With a New Issue of JASE

The March issue of JASE includes, “Comparing Costs of Noninvasive Cardiac Diagnostic Tests—a Population-Based Study.” Author Idan Roifman, MD, MSc, remarks, “In a large population-based cohort consisting of >2 million people from Ontario, Canada who were evaluated for chest pain, we report that receipt of any non-invasive test (NIT) for the diagnosis of coronary artery disease was associated with a 12% reduction in downstream costs when compared to no testing. Graded exercise stress testing (GXT) and stress echocardiography were associated with the least downstream costs (approximately 20% reductions), whereas CCTA and MPI were associated with the highest relative costs (approximately 30% and 25% increased costs, respectively). Our findings are important from a health policy perspective for the following reasons. First, we demonstrated that receipt of any NIT was associated with reductions in downstream costs when compared to no testing despite the added initial costs of the test itself. This is significant as it indicates that the initial cost of testing is more than offset by downstream healthcare cost savings. Second, given that stress imaging and anatomical testing have been demonstrated to be similar in terms of their related downstream clinical outcomes, our results reporting that stress echocardiography is the least expensive modality are important, as they may lead to prioritization of this test. This is especially important in healthcare systems that do not require pre-approval for stress echocardiography, but may require it for other types of NIT, such as many systems in the United States.”

This issue includes numerous clinical investigations reporting on safety of ultrasound enhancement agents, noninvasive testing for coronary heart disease, Doppler use in valvular heart disease, 3D TEE after transcatheter mitral valve repair and outcome, septal perforator flow in HCM, and LV function in children with chronic kidney disease. Don’t miss a Special Report on multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease. Additionally, there are two brief research communications—one explores low-dose application of ultrasound-enhancing agents without flush and the other reports on reproducibility of echocardiographic measures of aortic stenosis severity and its impact on severity grading. Five editorials accompany these reports, and a handful of letters to the editor on the topics of mitral regurgitation phenotype and moderate aortic stenosis conclude this issue.

With contributions from Rickey E. Carter, PhD, and David Ouyang, MD, FASE, Dr. Pellikka’s editorial outlines the artificial intelligence content of particular interest to JASE for authors interested in submitting on this topic. In accordance with International Congenital Heart Defects Awareness Day, Dr. Eidem’s President’s Message highlights congenital heart disease and ASE’s efforts to bring education and awareness to this important population during his presidency.

Be sure to check out March’s Author Spotlight to learn more from lead authors Mays T. Ali, MD, and Jeremy J. Thaden, MD, FASE, as they discuss their recent paper, Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. Please see the March ASE Education Calendar for a listing of educational opportunities far and wide.

Upcoming ASE Webinar: March 12

Register Now

Register now to attend ASE’s Women Leading in Echocardiography Laboratories: Challenges and Solutions webinar, taking place March 12, 7:00 – 8:00 PM ET. An expert panel of accomplished women leaders in echocardiography will share their success stories and discuss the specific challenges women encounter in echocardiography laboratories, including gender bias, work-life balance, and professional development hurdles. Attendees will discuss and propose effective strategies for overcoming these challenges and focus on mentorship, skill development, supportive work environments, and diversity and inclusion.

Attend ASEF’s 15th Annual Research Awards Gala

Registration for the Foundation’s 15th Annual Research Awards Gala is now OPEN! The ASE Foundation cordially invites you to attend our Crystal Gala, our premiere fundraising event honoring ASE’s 2024 award recipients and celebrating cardiovascular ultrasound research. Join us Saturday, June 15, at the Hyatt Regency Portland, for a wonderful evening of entertainment, dinner, and dancing.

Please note, Gala Registration options start with full tables and Supporter Level tickets first. Individual tickets at the Advocate, Benefactor, and Patron level may be available at a later date. Questions about the Gala? Please email Gala@ASEcho.org. Tickets will not be available on site. 

Read the February Echo Magazine

The February 2024 Echo magazine is now online! This issue contains interesting articles written by ASE members, including:

Each monthly issue includes articles or images related to cardiovascular ultrasound that are not research-related, as well as communications from the ASE President, Councils, Specialty Interest Groups, and the ASE education calendar. All active ASE members are eligible to submit articles to Echo magazineThe submission deadline for the May 2024 issue is March 15. Email Echo@ASEcho.org with questions.

Urgent Action – Contact Your Senators

Last Friday Senators John Boozman (R-AR) and Peter Welch (D-VT) along with 30 bipartisan cosigners sent a letter to Senate leaders calling for a legislative solution to protect access to Medicare services by canceling the 3.37% cut to physician Medicare payments that went into effect on January 1.

If your Senators signed the letter (click link for full list), we encourage you and your membership to reach out to their offices on social media, email or phone via the Senate switchboard to thank them for their support and to remind them that the job is not done.

Time is of the essence—in the coming days Congress is expected to take up the 2024 appropriation funding bills, and we must ensure that full relief from the devastating 3.37% cut is included in this package. Behind the scenes negotiations are ongoing and it’s imperative that your Senators are engaged in fixing the problem.

If your Senators did not sign the letter, it’s still important that you contact them and let them know how damaging these cuts are to physicians and their patients in your state.

For additional resources please visit fixmedicarenow.org for more information.

The time is now to cancel the cut!